NEW YORK (GenomeWeb News) – Enzo Biochem's shareholders have re-elected Barry Weiner and Bernard Kasten to continue serving on its board of directors for three-year terms, the company said in a filing with the US Securities and Exchange Commission this week.

Weiner is the company’s president, CFO, and principal accounting officer.


Lumora said this week that it has appointed Hayden Jeffreys to its board of directors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.